You are here: Industry Insights > COVID-19

News List

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns expresspharma
May 26, 2020
Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India expresspharma
May 26, 2020
Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India.
Airway Therapeutics and Celonic Enter COVID-19 Collaboration contractpharma
May 26, 2020
Will make AT-100 as promising new candidate for coronavirus, production expected to begin in June.
COVID-19 related delays to cancer treatment could cost thousands of lives, research shows pharmatimes
May 21, 2020
Scientists at the Institute of Cancer Research (ICR) are warning that delays to cancer surgery and other treatment caused by the COVID-19 pandemic could be linked to thousands of additional deaths in England.
First UK healthcare worker to enrol in COVID-19 prevention trial pharmatimes
May 21, 2020
The first UK frontline NHS worker will today enrol in a new study designed to test the potential of hydroxychloroquine to prevent infection with novel coronavirus.
Can-Fite announces pre-IND submission to US FDA for Piclidenoson in treatment of Covid-19 infected p pharmaceutical-business-review
May 21, 2020
Can-Fite BioPharma announced it has filed a pre-Investigational New Drug (IND) meeting request with the U.S. Food and Drug Administration (FDA) for its drug candidate Piclidenoson in the treatment of COVID-19 patients with moderate-to-severe symptoms.
10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing americanpharmaceuticalreview
May 21, 2020
10x Genomics and One Medical announced the two organizations are partnering to develop a path toward the safe return to work by deploying a comprehensive approach to COVID-19 testing, digital employee symptom screening ...
FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response americanpharmaceuticalreview
May 21, 2020
We are announcing another step in our effort to harness diverse streams of data to understand and respond to COVID-19.
Report reveals CMOs in Italy concentrated in worst-hit COVID-19 regions europeanpharmaceuticalreview
May 21, 2020
According to findings, the majority of CMOs in Italy are found in the locations hit worst by COVID-19, meaning the pharma supply chain has been greatly impacted.
Phlow secures $354m US contract for drug supply amid Covid-19 pharmaceutical-technology
May 21, 2020
US-based public benefit drug manufacturing corporation Phlow has received $354m funding from the government to produce essential medicines at risk of shortage amid the Covid-19 pandemic.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page